"In the first stage, UI has targeted to produce one thousand ventilators in a month to be distributed among COVID-19 referral hospitals through collaboration aimed at raising funds from various parties under the coordination of the Association of Alumni of the UI Technical Faculty (ILUNI FTUI)," Chief of the UI Ventilator Team Dr Basari, S.T., M. Eng noted in a written statement released on Friday.
Related news: Three domestic companies ready to produce thousands of ventilators
COVENT-20 will later undergo pre-clinical animal testing at the Indonesian Medical Education and Research Institute of the UI Medical School (IMERI FKUI) and clinical test at appointed hospitals before being produced en masse with its industrial partner.
"We are highly thankful to God that the ventilator we will develop has passed a test for two modes of ventilation. The advantage of multimode ventilator COVENT-20 is that it will assist medical workers in handling PDP (patients under surveillance) and COVID-19 positive patients while en route to the hospital aboard an ambulance and when they are being treated at the emergency unit (IGD)," Basari explained.
Multimode ventilator COVENT-20 is a Continuous Positive Airway Pressure (CPAP) model used for conscious patients under surveillance (PDPs), so their lungs only require oxygen delivered through positive pressure. The volume and frequency of breathing of patients is decided by their breath mechanism.
The Continuous Mandatory Ventilation (CMV) mode of ventilation is used for unconscious patients symptomatic with pneumonia and experiencing shortness of breath, for which a time-triggered machine is require to handle them
UI Rector Prof. Ari Kuncoro, SE, MA, Ph.D. stated that the cost to produce COVENT-20 is lower than that of the commercial transport ventilators available now.
Related news: Indonesia records 1,522 recoveries out of 10,118 confirmed cases
Related news: Indonesia channels spirit of 'gotong royong' in COVID-19 battle
EDITED BY INE